Abstract View

Author(s): Suryawanshi Sushmita C.1, Varade Gauri S.2, Wagh Vaishnavi V*.3, Chaudhari Sejal S.4, Prof. Yeole Kishor M.5

Email(s): 1waghvaishnavi2003@gmail.com

Address:

    DCS’s A R A College of Pharmacy, Nagaon, Dhule

Published In:   Volume - 4,      Issue - 5,     Year - 2025

DOI: https://doi.org/10.71431/IJRPAS.2025.4507  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Transdermal drug delivery systems offer several benefits because drugs administered are able to bypass hepatic first-pass metabolism and factors that alter pharmacokinetics in the gastrointestinal tract. Considering all problems associated with oral administration of anti-diabetic drug, attempt has been made to develop TDDS in order to achieve a better release pattern. Therefore, the present study involves the development of an anti-diabetic drug (metformin hydrochloride) in transdermal drug delivery form and their evaluation.

Cite this article:
Suryawanshi Sushmita C., Varade Gauri S., Wagh Vaishnavi V., Chaudhari Sejal S., Prof. Yeole Kishor M. Formulation and Evaluation of Transdermal Patches Containing Metformin for the Management of Gestational Diabetes. IJRPAS, May 2025; 4 (5): 69-75.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.4507


1. Goyal A, Kumar S, Nagpal M, Singh I, Arora S, Potential of Novel Drug Delivery Systems for Herbal Drugs. Indian Journal of pharmaceutical Research and Education 2011, 45(3): 225-235.

2. Nolte, MS, Karam JH. Pancreatic hormones and anti-diabetic drugs in Katzung BG (eds).  Basic and clinical pharmacology. Lange Medical Books/ McGraw-Hill Publishing Division,  New York. 2001; 8:711-734

3. Joshi C Suresh et al. Enhancement of transdermal delivery system and anti diabetic drug review. Int J Pharm 2012; 2(1):129-141

4. Chein YW. Controlled drug delivery fundamental and applications. 2nd ed, Robinson J.R., Vincent, H.L.L., Eds. Marcel dekker.inc., N.Y.1987:523-524

5. Hadgraft J, Lane M.E. Skin permeation: The years of enlightenment. Int J pharm 2005;

305:2-12.

6. Shaila L, Pandey S and Udupa N. Design and Evaluation of Matrix Type Membrane Controlled Transdermal Drug Delivery System of Nicotin Suitable for Use in Smoking Cessation. Indian Journ. Pharm. Sci. 2006;68: 179-184

7. Vyas Sp, Khar Rk. Targetted and Controlled Drug Delivery Novel Carrier System. 1st Ed. CBS Publishers and Distributors New Delhi. 2002; 411- 447.

8. Barry B. Transdermal Drug Delivery. In. Ed: Aulton M E Pharmaceutics: The science of Dosage form Design, Churchil Livingstone. 2002:499-533.

9. Darwhekar G, Jain Dk, Paditar Vk. Formulation and Evaluation of Transdermal Drug Delivery System of Clopidogrel Bisulfate. Asi. J. Pharmacy Life Sci. 2011; 1(3): 269-278.

10. Arunachalam A, Karthikeyan M, Kumar Vd, Prathap M, Sethuraman S, Ashutoshkumar S, Manidipa S. Transdermal Drug Delivery System: A Review. Current Pharma Res. 2010; 1(1):70-81.

11. Kumar Sr, Jain A, Nayak S. Development and Evaluation of Transdermal Patches of Colchicine. Der Pharmacia Lettre. 2012; 4(1): 330-343.

12. Patel, D., Sunita, A., Parmar B., Bhura N., Transdermal Drug Delivery System: A Review. The Pharma Innovation. 2012; 1(4): 66-75.

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags